Insurance implications for individuals with a high risk of breast and ovarian cancer in Europe

Dis Markers. 1999 Oct;15(1-3):159-65. doi: 10.1155/1999/748254.

Authors

P J Morrison¹, C M Steel, H F Vasen, D Eccles, D G Evans, P Møller, S Hodgson, D Stoppa-Lyonnet, J Chang-Claude, M Caligo, E Olah, N E Haites, N C Nevin

Affiliation

¹ Northern Ireland Regional Medical Genetics Centre, Belfast City Hospital Trust, UK. p.morrison@cableol.co.uk

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Breast Neoplasms / economics*
Breast Neoplasms / epidemiology
Breast Neoplasms / genetics
Europe / epidemiology
Female
Forecasting
Genetic Testing / economics
Genetic Testing / legislation & jurisprudence*
Guidelines as Topic
Humans
Insurance, Health* / legislation & jurisprudence
Male
Neoplastic Syndromes, Hereditary / economics*
Neoplastic Syndromes, Hereditary / epidemiology
Neoplastic Syndromes, Hereditary / genetics
Organizational Policy
Ovarian Neoplasms / economics*
Ovarian Neoplasms / epidemiology
Ovarian Neoplasms / genetics
Prejudice
Public Opinion
Risk
Risk Assessment
United Kingdom